Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1121: The Kaplan-Meier method is used for estimating what?

A. Survival (Correct Answer)
B. Prevalence
C. Incidence
D. Frequency

Explanation: ### Explanation **Correct Answer: A. Survival** The **Kaplan-Meier method** (also known as the product-limit method) is a non-parametric statistic used to estimate the **survival function** from time-to-event data. In medical research, it is the gold standard for analyzing "time to death" or "time to failure" of a treatment. The key strength of this method is its ability to handle **censored data**—cases where the event of interest (e.g., death) does not occur during the study period or the patient drops out. It calculates the probability of an event occurring at specific time intervals, resulting in the characteristic "step-ladder" **Kaplan-Meier Survival Curve**. **Why other options are incorrect:** * **B. Prevalence:** This refers to the total number of existing cases in a population at a given time. It is a "snapshot" and does not involve time-to-event analysis. * **C. Incidence:** This measures the number of *new* cases occurring in a population over a period. While it involves time, it does not account for the probability of survival or censored data like Kaplan-Meier. * **D. Frequency:** This is a general term for counts or proportions (like rates and ratios) and is not a specific statistical method for survival analysis. **High-Yield Clinical Pearls for NEET-PG:** * **Log-Rank Test:** This is the statistical test used to compare two different Kaplan-Meier survival curves (e.g., Drug A vs. Placebo). * **Hazard Ratio (HR):** Often reported alongside Kaplan-Meier; it represents the theoretical risk of an event occurring at any specific point in time. * **Median Survival Time:** This is the time point at which 50% of the study subjects are still alive; it is easily identified on a Kaplan-Meier plot where the curve crosses the 0.5 probability mark.

Question 1122: An investigator is studying the impact seatbelts have on the severity of injuries incurred during a motor vehicle accident. Which of the following study designs would be most appropriate for answering this question?

A. Case series
B. Case-control study (Correct Answer)
C. Cohort study
D. Clinical trial

Explanation: **Explanation:** The primary objective of this study is to investigate the association between an exposure (seatbelt use) and an outcome (severity of injury). **Why Case-Control is the Correct Answer:** In injury epidemiology, particularly for motor vehicle accidents (MVAs), the outcome (injury) has already occurred by the time the investigator begins the study. A **Case-Control study** is the most appropriate and practical design here. * **Cases:** Individuals who sustained severe injuries. * **Controls:** Individuals involved in similar accidents who sustained minor or no injuries. The investigator then looks **backwards in time** (retrospective) to determine the frequency of seatbelt use in both groups. This design is efficient for studying outcomes that are sudden or "acute" events like accidents. **Analysis of Incorrect Options:** * **A. Case Series:** This only describes a group of injured patients without a comparison group. It cannot establish an association or calculate risk. * **C. Cohort Study:** While theoretically possible, it is impractical and unethical to follow a group of people and wait for them to have accidents to see if seatbelts worked. It would require a massive sample size and a very long duration. * **D. Clinical Trial:** It is unethical to randomly assign one group to "no seatbelt" (the intervention) and expose them to the risk of injury in a trial setting. **NEET-PG High-Yield Pearls:** * **Directionality:** Case-control is "Retrospective" (Effect to Cause), whereas Cohort is "Prospective" (Cause to Effect). * **Measure of Association:** Case-control studies use **Odds Ratio (OR)**; Cohort studies use **Relative Risk (RR)**. * **Best for Rare Diseases:** Case-control is the design of choice for rare diseases or outcomes with long latency periods. * **Injury Epidemiology:** For sudden-onset events like MVAs or outbreaks, case-control is often the most feasible initial study design.

Question 1123: What is the quarantine period for yellow fever?

A. 1 day
B. 2 days
C. 6 days (Correct Answer)
D. 10 days

Explanation: **Explanation:** The quarantine period for a disease is defined as the maximum incubation period of that disease. For **Yellow Fever**, the maximum incubation period is **6 days**. 1. **Why 6 days is correct:** According to International Health Regulations (IHR), the incubation period for Yellow Fever ranges from 3 to 6 days. Therefore, travelers arriving from endemic zones without a valid vaccination certificate are placed under "quarantine" (isolation) for a period of 6 days from the date of last possible exposure to ensure they do not develop or spread the virus. 2. **Why other options are incorrect:** * **1 & 2 days:** These are too short and do not cover the full potential incubation window of the virus. * **10 days:** While the Yellow Fever vaccine becomes legally valid **10 days after administration** (the time required for protective antibodies to develop), it is not the duration of the quarantine period itself. **High-Yield NEET-PG Clinical Pearls:** * **Vaccine Validity:** The Yellow Fever vaccine (17D strain) is valid for **life** (as per WHO amendments since 2016), but for international travel purposes, it starts being valid 10 days after vaccination. * **Vector:** The primary vector is the *Aedes aegypti* mosquito. * **Quarantine vs. Isolation:** Quarantine applies to healthy people who were exposed; Isolation applies to infected/ill individuals. * **Other Quarantine Periods:** * Cholera: 5 days * Plague: 6 days * Yellow Fever: 6 days

Question 1124: Which of the following is the best indicator of the severity of a short-duration acute disease?

A. Cause-specific death rate
B. 5-year survival
C. Case fatality rate (Correct Answer)
D. Standardized mortality ratio

Explanation: **Explanation** **Case Fatality Rate (CFR)** is the best indicator of the **virulence** or **severity** of a disease. It represents the proportion of people diagnosed with a specific disease who die from it within a specified period. * **Formula:** (Total deaths from a disease / Total number of diagnosed cases of that disease) × 100. * **Why it is correct:** For short-duration acute diseases (e.g., Ebola, Cholera, or Meningococcemia), CFR directly measures the killing power of the pathogen. A high CFR indicates a more "severe" or "lethal" disease. **Analysis of Incorrect Options:** * **A. Cause-specific death rate:** This measures the mortality risk in the *entire population* (e.g., deaths per 1,000 people). It is influenced by both the severity of the disease and its prevalence in the community, making it a measure of the disease's overall burden rather than individual severity. * **B. 5-year survival:** This is the gold standard for assessing the prognosis and treatment effectiveness of **chronic diseases** (e.g., Cancers). It is irrelevant for short-duration acute illnesses. * **D. Standardized Mortality Ratio (SMR):** This is used to compare the observed deaths in a specific study group with the expected deaths in the general population. It is primarily used in occupational epidemiology to account for confounding factors like age. **High-Yield NEET-PG Pearls:** * **CFR vs. Mortality Rate:** CFR is a ratio (though often expressed as a percentage), while Mortality Rate is a true rate (includes time and population at risk). * **Complement of CFR:** The survival rate is (100 - CFR). * **Virulence:** In epidemiology, CFR is the primary clinical measure of a pathogen's virulence. * **Acute vs. Chronic:** Use CFR for acute infections; use 5-year survival for chronic conditions.

Question 1125: Reverse cold chain is used for which of the following purposes?

A. Carrying stool samples of polio patients from a PHC to the lab (Correct Answer)
B. Transporting outdated vaccines from PHC to a district hospital
C. Transporting vaccine to a lab to check its potency
D. Transporting vaccine from a camp to a sub-centre

Explanation: ### Explanation **Concept of Reverse Cold Chain** The **Cold Chain** is a system used to maintain the potency of vaccines by keeping them at recommended temperatures from the point of manufacture to the point of administration. Conversely, the **Reverse Cold Chain** is the process of maintaining the temperature of clinical samples (primarily stool) at **2°C to 8°C** while transporting them from the field/PHC to a laboratory. This is a critical component of the **Global Polio Eradication Initiative** for Acute Flaccid Paralysis (AFP) surveillance. **Why Option A is Correct:** To confirm a diagnosis of Polio, two stool samples must be collected 24–48 hours apart from an AFP patient. Since the Poliovirus is thermolabile, the samples must be kept cold to prevent the overgrowth of other bacteria and to ensure the virus remains viable for culture. The Reverse Cold Chain ensures these samples reach the laboratory in "good condition." **Analysis of Incorrect Options:** * **Option B:** Outdated vaccines are considered bio-medical waste or administrative returns; they do not require a cold chain for disposal or auditing. * **Option C:** While checking vaccine potency is important, the term "Reverse Cold Chain" is specifically and traditionally reserved for the transport of stool samples in AFP surveillance. * **Option D:** Transporting vaccines from a camp back to a sub-centre is simply a continuation of the standard **Cold Chain** protocol. **High-Yield Facts for NEET-PG:** * **AFP Surveillance:** Stool samples must be sent within **14 days** of the onset of paralysis. * **Temperature:** The ideal temperature for the Reverse Cold Chain is **2°C to 8°C**. * **Carrier:** A vaccine carrier with 4 fully frozen ice packs is typically used for this purpose. * **"Good Condition" Sample:** A sample is considered "good" if it arrives at the lab within 72 hours of collection, with the ice packs still frozen or at the required temperature, and no leakage.

Question 1126: The Naranjo algorithm is used for:

A. Assessing environmental factors affecting drug efficacy
B. Parametric-based data evaluation
C. Calculating the probability of adverse drug reactions (Correct Answer)
D. Evaluating demographic factors affecting drug action

Explanation: **Explanation:** The **Naranjo Algorithm** (or Naranjo Scale) is a standardized questionnaire used in clinical pharmacology and pharmacovigilance to determine the **causality** of an Adverse Drug Event. It consists of 10 objective questions (e.g., Did the reaction appear after the drug was administered? Did it improve when the drug was discontinued? Did it reappear upon rechallenge?). Each answer is assigned a score, and the total score categorizes the probability of the Adverse Drug Reaction (ADR) as: * **≥ 9:** Definite * **5–8:** Probable * **1–4:** Possible * **0:** Doubtful **Analysis of Incorrect Options:** * **Option A:** Environmental factors (like temperature or humidity) may affect drug stability, but the Naranjo scale specifically evaluates the clinical relationship between a drug and a patient's reaction. * **Option B:** Parametric data evaluation refers to statistical tests (like t-tests or ANOVA) used when data follows a normal distribution. Naranjo is a clinical scoring system, not a statistical distribution test. * **Option D:** While age or gender (demographics) can influence pharmacokinetics, the Naranjo algorithm focuses on the temporal and clinical link of the adverse event rather than demographic profiling. **High-Yield Clinical Pearls for NEET-PG:** * **WHO-UMC Scale:** Another common tool for ADR causality assessment (often compared with Naranjo). * **Pharmacovigilance:** The science of detecting, assessing, understanding, and preventing adverse effects. * **Yellow Card Scheme:** A famous spontaneous reporting system for ADRs (UK-based, but frequently asked). * **Pharmacovigilance Programme of India (PvPI):** Coordinated by the Indian Pharmacopoeia Commission (IPC).

Question 1127: In the control of communicable diseases, the period of quarantine in respect of a disease is determined by which of the following?

A. Incubation period (Correct Answer)
B. Infectivity period
C. Duration of illness
D. Carrier state

Explanation: ### Explanation **1. Why the Correct Answer is Right (Incubation Period)** Quarantine is defined as the limitation of freedom of movement of **well persons** or domestic animals who have been exposed to a communicable disease for a period of time not longer than the **longest usual incubation period** of the disease. The goal is to prevent the transmission of the disease during the stage when the individual might be subclinically infected but not yet symptomatic. Since the incubation period is the interval between the entry of the pathogen and the onset of clinical signs, monitoring a contact for this specific duration ensures they are truly "clear" before re-entering the community. **2. Why the Other Options are Incorrect** * **Infectivity Period:** This refers to the time during which an infectious agent may be transferred directly or indirectly from an infected person to another. This determines the duration of **Isolation**, not quarantine. * **Duration of Illness:** This is the clinical course of the disease. While it influences the period of isolation for a sick patient, it does not dictate the observation period for a healthy contact. * **Carrier State:** This refers to an individual who harbors the pathogen without showing clinical symptoms but can still spread it. While carriers are epidemiologically significant, quarantine is a standardized preventive measure based on the known incubation period of the pathogen. **3. NEET-PG High-Yield Pearls** * **Quarantine vs. Isolation:** Quarantine is for **healthy/exposed** contacts (applied at the group/community level); Isolation is for **sick/infected** cases (applied at the individual level). * **Absolute Quarantine:** Limitation of movement for the duration of the *longest* incubation period. * **Modified Quarantine:** Selective restriction (e.g., excluding a child from school). * **Key Concept:** The duration of **Isolation** is determined by the **Period of Communicability**.

Question 1128: What does the Sullivan index measure?

A. Measures disability
B. Measures life years adjusted with disability
C. Measures life expectancy adjusted for disability (Correct Answer)
D. Measures life expectancy

Explanation: ### Explanation **Sullivan’s Index** (also known as **Disability-Free Life Expectancy**) is a key indicator used in public health to measure the quality of survival. **1. Why the Correct Answer is Right:** The Sullivan index is calculated by subtracting the duration of bed disability and inability to perform major activities from the total life expectancy. It represents the **average number of years a person can expect to live without disability**. Unlike crude life expectancy, which only measures the quantity of life, this index provides a measure of the **quality of life** by adjusting for morbidity. **2. Analysis of Incorrect Options:** * **Option A (Measures disability):** While it incorporates disability data, it is not a measure of disability alone. Measures like "Prevalence" or "Incidence" of specific conditions quantify disability. * **Option B (Measures life years adjusted with disability):** This refers to **DALY (Disability-Adjusted Life Years)**. DALY is a measure of the *burden of disease* (Years of Life Lost + Years Lived with Disability), whereas Sullivan’s index is a measure of *health expectancy*. * **Option D (Measures life expectancy):** This is a measure of mortality only. It indicates how long a person is expected to live but does not account for the health status or disability during those years. **3. High-Yield Clinical Pearls for NEET-PG:** * **Sullivan’s Index** is considered one of the most advanced and useful indicators of relevant health status. * **DALY vs. Sullivan Index:** DALY measures "lost" years (negative indicator), while Sullivan Index measures "healthy" years (positive indicator). * **HALE (Health-Adjusted Life Expectancy):** Often used interchangeably with Sullivan’s index in broader contexts, it is the equivalent of the number of years in full health that a newborn can expect to live. * **QALY (Quality-Adjusted Life Year):** Used primarily in cost-effectiveness analysis to measure the benefit of a medical intervention.

Question 1129: Immunity by vaccination is:

A. Active natural
B. Passive natural
C. Active acquired (Correct Answer)
D. Passive acquired

Explanation: **Explanation:** Immunity is broadly classified based on how the body acquires protection against pathogens. The correct answer is **Active Acquired Immunity**. **1. Why Active Acquired?** * **Active:** This means the individual’s own immune system is stimulated to produce antibodies or specialized cells (T-cells). In vaccination, an antigen (live-attenuated, killed, or subunit) is introduced, triggering the body’s immune machinery to create a memory response. * **Acquired (Artificial):** This refers to immunity obtained through deliberate medical intervention rather than natural exposure. **2. Analysis of Incorrect Options:** * **Active Natural:** This occurs when a person is naturally infected by a disease-causing agent (e.g., developing lifelong immunity after a natural Measles infection). * **Passive Natural:** This involves the transfer of pre-formed antibodies from mother to child via the placenta (IgG) or breast milk (IgA). The recipient’s immune system remains passive. * **Passive Acquired (Artificial):** This involves the administration of ready-made antibodies (immunoglobulins or antisera) for immediate protection, such as Anti-Rabies Serum (ARS) or Tetanus Immunoglobulin (TIG). **High-Yield Clinical Pearls for NEET-PG:** * **Speed vs. Duration:** Active immunity takes time to develop (latent period) but is long-lasting. Passive immunity is immediate but temporary. * **Adoptive Immunity:** A subset of acquired immunity achieved by transferring immunocompetent cells (like lymphocytes), often used in bone marrow transplants. * **Combined Immunization:** Giving both active (vaccine) and passive (IG) components simultaneously at different sites (e.g., Post-exposure prophylaxis for Rabies or Hepatitis B).

Question 1130: In a case-control study, the disease is found to be more common in the group consuming coffee compared to the control group. What is the significance of this finding?

A. A cause and effect relationship has been established.
B. The median of the disease can be calculated.
C. Caffeine is associated with the occurrence of the disease. (Correct Answer)
D. Controls will not develop the disease.

Explanation: ### Explanation **1. Why Option C is Correct:** In epidemiology, a **Case-Control Study** is an observational, analytical study designed to identify associations between an exposure (coffee/caffeine) and an outcome (disease). When a factor is found more frequently in the "cases" than in the "controls," it indicates a **statistical association**. This means the exposure and the disease occur together more often than would be expected by chance. However, an association does not automatically imply that the exposure *caused* the disease. **2. Why Other Options are Incorrect:** * **Option A:** A case-control study alone cannot establish a **cause-and-effect relationship**. Causality requires meeting the "Bradford Hill Criteria" (e.g., temporality, strength, dose-response) and is better supported by Cohort studies or Randomized Controlled Trials (RCTs). * **Option B:** Case-control studies do not measure the "median" of a disease. They primarily measure the **Odds Ratio (OR)**. Since the study starts with diseased individuals, it cannot calculate Incidence or the median duration/onset of the disease in the general population. * **Option C:** This is a false premise. Controls are chosen because they do not have the disease *at the start of the study*, but they remain at risk and could potentially develop the disease in the future. **3. High-Yield Clinical Pearls for NEET-PG:** * **Direction of Study:** Retrospective (Proceeds from Effect to Cause). * **Measure of Association:** Odds Ratio (OR). * **Key Advantage:** Best for studying **rare diseases** or diseases with long latency periods. * **Key Disadvantage:** Highly prone to **Recall Bias** and Selection Bias. * **Matching:** Done in case-control studies to eliminate the effects of confounding variables.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free